Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Post by cannhealthon May 10, 2019 2:09pm
199 Views
Post# 29735274

D'Accord Loonie..

D'Accord Loonie..
Regarding all of your posts today.. I'm in agreement with most you've said regarding the forward-looking potential for EMH revenue and, consequent, SP leaps. I view EMH shares somewhat akin to a coiled spring building pressure with a "happy ending" for investors wise enough to Buy and Hold until the inevitable 'release'.

This said, and irrespective of IR's assertions that EMS' consulting fees are justified, I'd like to see them cut by half to decrease the EPS losses until EMH is profitable. Given Emerald Health Sciences is a privately held company, as shareholders, we've no way of knowing how that consulting money is spent.. which seems to account for at least $0.03-$0.04 per share loss in the recent Qtr.
<< Previous
Bullboard Posts
Next >>